The empty capsules market continues to evolve as pharmaceutical and nutraceutical manufacturers respond to changing formulation requirements, regulatory expectations, and supply chain dynamics. While cost remains an important sourcing factor, companies are increasingly evaluating capsule materials, manufacturing capabilities, and long-term supply resilience.
According to Future Market Insights, the global market is expected to maintain steady growth over the next decade, driven by innovation across both pharmaceutical and nutraceutical applications.
Empty Capsule Market Size and Growth Outlook
The latest empty capsule market size projections from Future Market Insights estimate the global empty capsules market at approximately USD 3.7 billion in 2026, with the market expected to reach USD 7.4 billion by 2036, representing a compound annual growth rate (CAGR) of 8.1%.
Oral dosage forms remain the industry's primary delivery format, accounting for 87.4% of capsule demand in 2026. At the same time, pharmaceuticals continue to dominate consumption, representing 61.3% of total end-use, reflecting the continued expansion of prescription medicines, specialty therapies, and generic drug manufacturing.
Despite rapid innovation across dosage technologies, hard capsules remain one of the most established and scalable delivery systems for both pharmaceutical capsules and nutraceutical capsules.
Empty Capsules Market Trends Reshaping Capsule Manufacturing
Several empty capsules market trends are influencing procurement and product development decisions in 2026.
Material diversification continues to gain momentum. Although gelatin capsules still represent roughly 60.2% of global demand, manufacturers are steadily expanding portfolios that include vegetarian capsules, plant-based capsules, and HPMC capsules. These alternatives address growing requirements for vegan formulations, moisture-sensitive ingredients, clean-label positioning, and broader dietary compatibility.
At the same time, capsule manufacturing trends increasingly emphasize formulation flexibility rather than a one-material-fits-all approach. Selection is becoming more application-driven, balancing ingredient stability, dissolution performance, regulatory requirements, and consumer preferences.
For manufacturers, this means sourcing strategies increasingly rely on suppliers capable of supporting multiple capsule technologies instead of a single product platform.
Supply Chain Dynamics Continue to Influence Capsule Manufacturing
While demand continues to expand, the supply side presents new challenges.
One of the most closely monitored issues is pricing pressure affecting gelatin capsules. Reduced bovine processing capacity in the United States, reported by the USDA, has tightened raw material availability, contributing to increased volatility throughout portions of the gelatin supply chain.
At the same time, demand remains resilient. According to the Association for Accessible Medicines, generic medicines account for approximately 90% of prescriptions dispensed in the United States, creating stable long-term demand for reliable capsule manufacturing capacity despite fluctuations in raw material costs.
Market evolution is not only visible in manufacturing investments, but also in how established companies position themselves for the future. Lyfe Group's recent transition from the CapsCanada brand reflects a broader focus on supporting the pharmaceutical and nutraceutical industries while continuing to build on decades of experience in empty capsule manufacturing.
Continue Reading
Capsule Supply Solutions for Supply Chain Efficiency
How CapsCanada Ensures Reliable Capsule Supply
Regional Manufacturing Is Becoming a Strategic Advantage
Beyond product specifications, sourcing decisions increasingly consider manufacturing location and supply continuity. Regional production can improve responsiveness, reduce logistics complexity, and strengthen long-term supply reliability, particularly for companies serving the pharmaceutical and nutraceutical industries throughout the Americas.
As a capsule manufacturer proudly based in the Americas, Lyfe Group (formerly CapsCanada), continues to support customers with locally manufactured capsule solutions backed by global distribution.
What This Means for Capsule Buyers
The 2026 empty capsules market reflects an industry balancing sustained demand with evolving formulation needs and increasingly complex supply chains. While gelatin remains the largest product category, continued adoption of HPMC and other plant-based alternatives demonstrates that flexibility has become a strategic advantage rather than a niche requirement.
For manufacturers evaluating future sourcing strategies, understanding market direction is becoming as important as comparing technical specifications. At Lyfe Group, we continue to monitor market developments and share practical insights that help manufacturers better understand the forces shaping the empty capsule industry. Explore our blog for more perspectives on capsule technologies, formulation trends, and industry developments.
